Olodaterol clinical trials
Also written BI 1744 CL.
Counted the way a researcher would: Olodaterol with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses olodaterol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 31 Jul 2014 · STRIVERDI RESPIMAT · NDA 203108 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
59 studies that test it; most in 2009 (10)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 10 |
| 2010 | 7 |
| 2011 | 2 |
| 2012 | 8 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 5 |
| 2020 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 54 · Other 5
Boehringer Ingelheim (54) · University of Dundee (2) · Yonsei University (1) · Erasme University Hospital (1) · Queen's University (1)
Often tested with
Tested in the same studies.
Tiotropium (12) · Fluticasone furoate (1) · Fluticasone (1) · Vilanterol (1)
Related medicines
As reviewed, each with the page that says it.
- One of Bronchodilators source
Studies
Open first, then newest update. How each study uses olodaterol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 59
- Effects of Tiotropium/Olodaterol on Cardio-pulmonary Exercise Capacity in Patients With Hyperinflated Chronic Obstructive Pulmonary Disease [ACHIEVE]CompletedNot applicableYonsei UniversityNCT04994574Written as tiotropium/olodaterolHow we know
- Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPDCompletedPhase 3Erasme University HospitalNCT05927155Written as LABAHow we know
- A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to InhaleCompletedPhase 4Boehringer IngelheimNCT04223843Written as Tiotropium + olodaterolHow we know
- INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and OlodaterolCompletedPhase 4University of DundeeNCT03152149Written as Tiotropium & olodaterolHow we know
- The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the DiskusCompletedPhase 4Boehringer IngelheimNCT03240575Written as OlodaterolHow we know
- Effect of Tiotropium + Olodaterol on Breathlessness in COPD PatientsCompletedPhase 4Boehringer IngelheimNCT02853123Written as OlodaterolHow we know
- Cardiovascular Function in COPD PatientsCompletedPhase 4Boehringer IngelheimNCT03055988Written as OlodaterolHow we know
- Ultra-long Acting Bronchodilator Therapy in Smoking AsthmaticsCompletedPhase 4University of DundeeNCT02682862Written as olodaterol hydrochloride 2.5mcg, tiotropium bromide 2.5mcgHow we know
- Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD PatientsCompletedPhase 3Boehringer IngelheimNCT02629965Written as olodaterolHow we know
- Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD PatientsCompletedPhase 1Boehringer IngelheimNCT02969317Written as OlodaterolHow we know
- Effects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPDCompletedPhase 4Queen's UniversityNCT03425617Written as Tiotropium + OlodaterolHow we know
- Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.CompletedPhase 3Boehringer IngelheimNCT02296138Written as olodaterolHow we know
- To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of AirwaysCompletedPhase 3Boehringer IngelheimNCT02085161Written as tiotropium+olodaterolHow we know
- A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPDCompletedPhase 3Boehringer IngelheimNCT01525615Written as tiotropium+olodaterol (low dose)How we know
- Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD PatientsCompletedPhase 3Boehringer IngelheimNCT01969721Written as olodaterolHow we know
- Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary DiseaseCompletedPhase 3Boehringer IngelheimNCT00932646Written as BI 1744 (Olodaterol) Low DoseHow we know
- Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)CompletedPhase 3Boehringer IngelheimNCT02006732Written as olodaterolHow we know
- Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 1Boehringer IngelheimNCT02231177Written as BI 1744 CLHow we know
- Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)CompletedPhase 3Boehringer IngelheimNCT01964352Written as olodaterolHow we know
- Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.CompletedPhase 3Boehringer IngelheimNCT01533935Written as Tiotropium + OlodaterolHow we know
See all 59 studies that test olodaterol →
Given beside what is tested · 4 — olodaterol is usual care or a partner of the new treatment
- Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPDSuspendedNot applicableMedical University of BialystokNCT07541378Written as OlodaterolHow we know
- Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPDCompletedPhase 2Verona Pharma plcNCT03673670Written as Tiotropium/olodaterol (Respimat)How we know
- Relative Bioavailability of of Olodaterol and KetoconazoleCompletedPhase 1Boehringer IngelheimNCT01153711Written as BI 1744How we know
- Olodaterol Bridging Study in AsthmaWithdrawnPhase 2Boehringer IngelheimNCT01428622Written as OlodaterolHow we know
As the comparator · 2 — what is tested is compared with olodaterol
Codes
What other systems call olodaterol · ClinicalTrials.gg INT005634
- MeSH (NLM) C549647olodaterolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) VD2YSN1AFDOLODATEROLConfirmed FDA, NLM, Wikidata
- RxNorm 1546059Confirmed FDA, Wikidata
- Wikidata Q7088466olodaterolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C170249OlodaterolOne source FDA
- DrugBank DB09080One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C549647 | olodaterol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | VD2YSN1AFD | OLODATEROL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1546059 | — | Confirmed FDA, Wikidata |
| Wikidata | Q7088466 | olodaterol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C170249 | Olodaterol | One source FDA |
| DrugBank | DB09080 | — | One source Wikidata |
Also registered as olodaterol hydrochloride (UNII 65R445W3V9 · RxNorm 1546396).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.